UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors

Journal for immunotherapy of cancer, 2016-10, Vol.4 (1), p.61-61, Article 61

2016

Volltextzugriff (PDF)

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Clinical cancer research, 2022-12, Vol.28 (24), p.5317-5329

2022

Volltextzugriff (PDF)

Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Oral oncology, 2024-07, Vol.154, p.106866, Article 106866

2024

Volltextzugriff (PDF)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Frontiers in oncology, 2018-03, Vol.8, p.44-44

2018

Volltextzugriff (PDF)

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

Journal for immunotherapy of cancer, 2023-10, Vol.11 (10), p.e007288

2023

Volltextzugriff (PDF)

Biomarkers on melanoma patient T cells associated with ipilimumab treatment

Journal of translational medicine, 2012-07, Vol.10 (1), p.146-146, Article 146

2012

Volltextzugriff (PDF)

351 Expansion of T cells from the cerebrospinal fluid of melanoma patients with leptomeningeal disease

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A400-A400

2023

Volltextzugriff (PDF)

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

Oncoimmunology, 2018-09, Vol.7 (9), p.e1476816-e1476816

2018

Volltextzugriff (PDF)

346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A395-A395

2023

Volltextzugriff (PDF)

384 An investigation into the role of CD4+ tumor-infiltrating lymphocytes (TIL) in metastatic melanoma patients with a complete response to adoptive cell therapy

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A418-A418

2021

Volltextzugriff (PDF)

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P19-P19, Article P19

2015

Volltextzugriff (PDF)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P49-P49, Article P49

2015

Volltextzugriff (PDF)

Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy

Molecular therapy, 2020-10, Vol.28 (10), p.2252-2270

2020

Volltextzugriff (PDF)

Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells

The Journal of immunology (1950), 2020-11, Vol.205 (10), p.2893-2904

2020

Volltextzugriff (PDF)

Intratumoral activation of 41BB co-stimulatory signals enhances CD8 T cell expansion and modulates tumor-infiltrating myeloid cells

The Journal of immunology (1950), 2020-10, Vol.205 (10), p.2893-2904

2020

Volltextzugriff (PDF)

Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients

International immunopharmacology, 2021-05, Vol.94, p.107481-107481, Article 107481

2021

Volltextzugriff (PDF)

Abstract 1513: A case study investigation into the role of CD4+ tumor-infiltrating lymphocytes in a metastatic melanoma patient with a complete response to adoptive cell therapy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1513-1513

2021

Volltextzugriff (PDF)

Utilizing Neoantigen-Specific CD4+ T Cells and Immune Checkpoint Modulation to Advance Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Patients

Hall, MacLean Scott

2023

Volltextzugriff (PDF)

TRSC-05 TUMOR REACTIVE T CELLS FROM THE CEREBROSPINAL FLUID IN MELANOMA LEPTOMENINGEAL DISEASE

Neuro-oncology advances, 2024-08, Vol.6 (Supplement_1), p.i40-i40

2024

Volltextzugriff (PDF)

Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

Clinical cancer research, 2011-02, Vol.17 (4), p.896-906

2011

Volltextzugriff (PDF)

Abstract 2178: Expansion of tumor-specific tumor-infiltrating lymphocytes (TIL) from head and neck tumors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2178-2178

2020

Volltextzugriff (PDF)

Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function

Journal of immunotherapy (1997), 2021-02, Vol.44 (2), p.63

2021

Volltextzugriff (PDF)

The importance of CD4+ Tumor-Infiltrating Lymphocytes (TIL) in Adoptive Cell Transfer

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.239-239.6

2020

Volltextzugriff (PDF)

MP48-20 EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TIL) FROM PRIMARY BLADDER TUMORS

The Journal of urology, 2017-04, Vol.197 (4), p.e645-e645

2017

Volltextzugriff (PDF)

Recirculation and retention contribute to a population of mature Tregs in the thymus. (P1153)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.50-50.19

2013

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

Biomarkers on melanoma patient T cells associated with ipilimumab treatment

351 Expansion of T cells from the cerebrospinal fluid of melanoma patients with leptomeningeal disease

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers

384 An investigation into the role of CD4+ tumor-infiltrating lymphocytes (TIL) in metastatic melanoma patients with a complete response to adoptive cell therapy

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma

Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy

Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells

Intratumoral activation of 41BB co-stimulatory signals enhances CD8 T cell expansion and modulates tumor-infiltrating myeloid cells

Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients

Abstract 1513: A case study investigation into the role of CD4+ tumor-infiltrating lymphocytes in a metastatic melanoma patient with a complete response to adoptive cell therapy

Utilizing Neoantigen-Specific CD4+ T Cells and Immune Checkpoint Modulation to Advance Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Patients

TRSC-05 TUMOR REACTIVE T CELLS FROM THE CEREBROSPINAL FLUID IN MELANOMA LEPTOMENINGEAL DISEASE

Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

Abstract 2178: Expansion of tumor-specific tumor-infiltrating lymphocytes (TIL) from head and neck tumors

Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function

The importance of CD4+ Tumor-Infiltrating Lymphocytes (TIL) in Adoptive Cell Transfer

MP48-20 EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TIL) FROM PRIMARY BLADDER TUMORS

Recirculation and retention contribute to a population of mature Tregs in the thymus. (P1153)

Suchergebnisse filtern